A randomized, double-blind, placebo-controlled trial of a COX-2 inhibitor (Rofecoxib) in patients undergoing coronary artery bypass surgery
2006 ◽
Vol 5
(2)
◽
pp. 101-104
◽
2009 ◽
Vol 109
(1)
◽
pp. 15-24
◽
2006 ◽
Vol 96
(2)
◽
pp. 171-178
◽
2013 ◽
Vol 16
(3)
◽
pp. 180
◽